Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
8881
Effects of activators and inhibitors on TcPiezo channels.
Published 2025“…Downregulation of <i>TcPiezo2</i> expression (+Tet) showed a significant decrease of lysosomal Ca<sup>2+</sup> release as in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1013105#ppat.1013105.g004" target="_blank">Fig 4A</a>. …”
-
8882
Scatterplots of respiratory rate and age by sex.
Published 2025“…<div><p>Objective</p><p>The aim of the study was to derive median age- and sex-specific respiratory rates in a population-based sample of adults and to identify disease and lifestyle factors associated with elevated respiratory rates.…”
-
8883
Flow chart of the study population.
Published 2025“…<div><p>Objective</p><p>The aim of the study was to derive median age- and sex-specific respiratory rates in a population-based sample of adults and to identify disease and lifestyle factors associated with elevated respiratory rates.…”
-
8884
The study flowchart.
Published 2024“…The short-term cohort had 23 intervention and 29 control participants, while the long-term cohort had 35 and 22, respectively. There was a significant improvement in non-HDL-C levels in the short-term intervention group compared to the control group. …”
-
8885
-
8886
The flow chart of the study.
Published 2025“…Hematocrit in the first 2 hours of life, considered as a continuous variable, was significantly associated with short-term outcomes in univariate analyses (P < 0.05). …”
-
8887
Baseline characteristics of participants.
Published 2025“…Hematocrit in the first 2 hours of life, considered as a continuous variable, was significantly associated with short-term outcomes in univariate analyses (P < 0.05). …”
-
8888
Table 2_Association of cardiorespiratory fitness with phenotypic age in younger population: a study based on the NHANES database.docx
Published 2025“…Interestingly, in the population of over 29 years’ old, a significant interaction between obesity and impaired CRF for PAA was observed (p = 0.018; p = 0.026).…”
-
8889
Table 1_Association of cardiorespiratory fitness with phenotypic age in younger population: a study based on the NHANES database.docx
Published 2025“…Interestingly, in the population of over 29 years’ old, a significant interaction between obesity and impaired CRF for PAA was observed (p = 0.018; p = 0.026).…”
-
8890
Table1_Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data.DOCX
Published 2025“…Unforeseen significant AEs such as unintended pregnancy (n = 623; ROR, 6.65; ROR025, 6.1; χ<sup>2</sup>, 2,482.38; PRR, 6.41; EBGM, 5.69; EBGM05, 5.29), bone pain (n = 35; ROR, 13.78; ROR025, 9.4; χ<sup>2</sup>, 311.2; PRR, 13.75; EBGM, 10.59; EBGM05, 7.69), gait disturbance (n = 34; ROR, 2.82; ROR025, 1.99; χ<sup>2</sup>, 37.31; PRR, 2.88; EBGM, 2.7; EBGM05, 2.02), dental caries (n = 15; ROR, 23.16; ROR025, 12.32; χ<sup>2</sup>, 204.26; PRR, 23.14; EBGM, 15.23; EBGM05, 8.98), decrease in blood pressure (n = 15; ROR, 3.88; ROR025, 2.29; χ<sup>2</sup>, 29.35; PRR, 3.88; EBGM, 3.63; EBGM05, 2.33), and osteonecrosis (n = 9; ROR, 23.44; ROR025, 10.36; χ<sup>2</sup>, 123.67; PRR, 23.43; EBGM, 15.35; EBGM05, 7.75) were identified as AEs that were not previously outlined in the prescribing information of the medication.…”
-
8891
Table1_Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data.DOCX
Published 2024“…Unforeseen significant AEs such as unintended pregnancy (n = 623; ROR, 6.65; ROR025, 6.1; χ<sup>2</sup>, 2,482.38; PRR, 6.41; EBGM, 5.69; EBGM05, 5.29), bone pain (n = 35; ROR, 13.78; ROR025, 9.4; χ<sup>2</sup>, 311.2; PRR, 13.75; EBGM, 10.59; EBGM05, 7.69), gait disturbance (n = 34; ROR, 2.82; ROR025, 1.99; χ<sup>2</sup>, 37.31; PRR, 2.88; EBGM, 2.7; EBGM05, 2.02), dental caries (n = 15; ROR, 23.16; ROR025, 12.32; χ<sup>2</sup>, 204.26; PRR, 23.14; EBGM, 15.23; EBGM05, 8.98), decrease in blood pressure (n = 15; ROR, 3.88; ROR025, 2.29; χ<sup>2</sup>, 29.35; PRR, 3.88; EBGM, 3.63; EBGM05, 2.33), and osteonecrosis (n = 9; ROR, 23.44; ROR025, 10.36; χ<sup>2</sup>, 123.67; PRR, 23.43; EBGM, 15.35; EBGM05, 7.75) were identified as AEs that were not previously outlined in the prescribing information of the medication.…”
-
8892
Image 1_Effects of ultraviolet radiation as a climate variable on the geographic distribution of Oryza sativa under climate change based on Biomod2.tif
Published 2025“…In the future climate scenario, the total suitable habitat area of O. sativa tended to decrease, but the suitable distribution area under the influence of UV was larger than that without UV.…”
-
8893
Roxadustat has risks of reversible central hypothyroidism in patients undergoing hemodialysis: a single-center retrospective cohort study
Published 2024“…TSH levels were significantly decreased from a median of 2.46 (interquartile range:1.60–4.51) mU/L before roxadustat treatment to 1.36 (0.72–2.41) mU/L during treatment (<i>p</i> < 0.001), and improved to 2.56 (1.78–4.63) mU/L after halting roxadustat (<i>p</i> < 0.001). …”
-
8894
Modulating the Coordination Environment of Cu-Embedded Mo<i>X</i><sub>2</sub> (<i>X</i> = S, Se, and Te) Monolayers for Electrocatalytic Reduction of CO<sub>2</sub> to CH<sub>4</su...
Published 2024“…Our results demonstrate that the local coordination environment in SACs has a significant impact on the catalytic activity of CO<sub>2</sub>RR.…”
-
8895
Data Sheet 1_Real world evidence of dupilumab effectiveness in a Colombian cohort of patients diagnosed with severe asthma.docx
Published 2025“…FeNO and absolute eosinophil counts throughout the observed period was also explored.</p>Results<p>A total of 98 patients were included. …”
-
8896
Supplementary Material for: Safety profile of intravitreal Dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies.
Published 2025“…In general, the peak IOP increase was typically observed 60 days post-DEX-i injection, followed by a decrease in the subsequent months. …”
-
8897
Table 2_Tofacitinib extends survival in a mouse model of ALS through NK cell-independent mechanisms.xlsx
Published 2025“…Tofacitinib, an FDA-approved janus kinase (Jak) and signal transducer and activator (STAT) pathway inhibitor, reduces NK cytotoxicity and decreases overall levels in peripheral blood and may represent a potential ALS therapy. …”
-
8898
Table 1_Tofacitinib extends survival in a mouse model of ALS through NK cell-independent mechanisms.xlsx
Published 2025“…Tofacitinib, an FDA-approved janus kinase (Jak) and signal transducer and activator (STAT) pathway inhibitor, reduces NK cytotoxicity and decreases overall levels in peripheral blood and may represent a potential ALS therapy. …”
-
8899
Table 1_Plant-based diets and total and cause-specific mortality: a meta-analysis of prospective studies.docx
Published 2025“…Participants in the highest quintile of both the PDI and hPDI had a significantly decreased risk of all-cause mortality (pooled HR<sub>PDI</sub> = 0.85; 95% CI: 0.80–0.90; pooled HR<sub>hPDI</sub> = 0.86; 95% CI: 0.81–0.92) compared to participants in the lowest quintile. …”
-
8900
Table 1_Association between androgenetic alopecia and psychological well-being: a systematic review and meta-analysis.docx
Published 2025“…However, no significant difference was observed in general distress (pooled SMD = -0.01, 95% CI [-0.39,0.37], p = 0.97). …”